Animal models for viral haemorrhagic fever

被引:12
|
作者
Falzaran, D. [1 ,2 ]
Bente, D. A. [1 ]
机构
[1] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Programme, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
关键词
RIFT-VALLEY FEVER; LASSA VIRUS-INFECTION; FOREST-DISEASE VIRUS; RHESUS-MONKEY MODEL; PROTECT GUINEA-PIGS; EBOLA-VIRUS; YELLOW-FEVER; DENGUE VIRUS; MOUSE MODEL; COMPARATIVE PHYSIOLOGY;
D O I
10.1111/1469-0691.12630
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Viral haemorrhagic fever can be caused by one of a diverse group of viruses that come from four different families of RNA viruses. Disease severity can vary from mild self-limiting febrile illness to severe disease characterized by high fever, high-level viraemia, increased vascular permeability that can progress to shock, multi-organ failure and death. Despite the urgent need, effective treatments and preventative vaccines are currently lacking for the majority of these viruses. A number of factors preclude the effective study of these diseases in humans including the high virulence of the agents involved, the sporadic nature of outbreaks of these viruses, which are typically in geographically isolated areas with under-serviced diagnostic capabilities, and the requirements for high level bio-containment. As a result, animal models that accurately mimic human disease are essential for advancing our understanding of the pathogenesis of viral haemorrhagic fevers. Moreover, animal models for viral haemorrhagic fevers are necessary to test vaccines and therapeutic intervention strategies. Here, we present an overview of the animal models that have been established for each of the haemorrhagic fever viruses and identify which aspects of human disease are modelled. Furthermore, we discuss how experimental design considerations, such as choice of species and virus strain as well as route and dose of inoculation, have an influence on animal model development. We also bring attention to some of the pitfalls that need to be avoided when extrapolating results from animal models. (C) 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
引用
收藏
页码:E17 / E27
页数:11
相关论文
共 50 条
  • [41] Dengue fever and dengue haemorrhagic fever
    John, TJ
    LANCET, 2003, 361 (9352): : 181 - 182
  • [42] Omsk haemorrhagic fever
    Ruzek, Daniel
    Yakimenko, Valeriy V.
    Karan, Lyudmila S.
    Tkachev, Sergey E.
    LANCET, 2010, 376 (9758): : 2104 - 2113
  • [43] ORIGINAL HAEMORRHAGIC FEVER - YELLOW FEVER
    DENNIS, LH
    REISBERG, BE
    CROSBIE, J
    CROZIER, D
    CONRAD, ME
    BRITISH JOURNAL OF HAEMATOLOGY, 1969, 17 (05) : 455 - +
  • [44] Haemorrhagic typhoid fever
    Caddy, A
    Molony, B
    LANCET, 1914, 2 : 147 - 149
  • [45] HAEMORRHAGIC FEVER IN KOREA
    BERNSTEIN, C
    LANCET, 1952, 263 (DEC27): : 1273 - 1273
  • [46] Ebola Haemorrhagic Fever
    不详
    SAUDI MEDICAL JOURNAL, 2000, 21 (12) : 1201 - 1202
  • [47] Zoonoses and haemorrhagic fever
    Mahy, BWJ
    SAFETY OF BIOLOGICAL PRODUCTS PREPARED FROM MAMMALIAN CELL CULTURE, 1998, 93 : 31 - 36
  • [48] HAEMORRHAGIC FEVER IN SINGAPORE
    STRANSKY, E
    LANCET, 1961, 1 (718): : 1169 - &
  • [49] EPIDEMIC HAEMORRHAGIC FEVER
    不详
    LANCET, 1954, 2 (JUL31): : 239 - 240
  • [50] Ebola haemorrhagic fever
    Rollin, PE
    Ksiazek, TG
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (01) : 1 - 2